Key Takeaways
- • IFF has agreed to sell its Food Ingredients business to CVC Capital Partners for $4.3 billion, with IFF retaining a 10% minority equity stake valued at approximately $200 million and a board seat in the new entity.
- • The Food Ingredients business generated $3.1 billion in annual sales and $430 million of EBITDA in 2025, positioning it as a significant scale asset within the specialty ingredients sector.
- • The transaction represents a strategic portfolio transformation enabling IFF to concentrate resources on higher-growth, higher-margin segments: Taste, Scent, and Health & Biosciences, while maintaining upside participation through its retained minority interest.
- • CEO Erik Fyrwald framed the deal as enabling accelerated innovation and R&D investment in IFF's core biotechnology and naturals capabilities, while strengthening the company's balance sheet.
- • This transaction ranks among the largest ingredients sector deals and signals continued consolidation activity in specialty chemicals and food ingredients under private equity ownership.
Summary
International Flavors & Fragrances (IFF) has entered into a definitive agreement to sell its Food Ingredients business to funds advised by CVC Capital Partners for $4.3 billion. As part of the transaction structure, IFF will retain an approximately 10% minority equity interest valued at roughly $200 million, positioning the company to participate in future value creation under CVC's ownership while maintaining governance visibility through a board seat.
The Food Ingredients business represents a substantial asset on IFF's balance sheet. In 2025, the division generated nearly $3.1 billion in annual sales and approximately $430 million of EBITDA, reflecting meaningful profitability across a diversified portfolio that includes texturants, emulsifiers, plant-based solutions, and specialty ingredients serving multinational food and beverage customers. The deal values this business at an enterprise value implying an approximate 10x EBITDA multiple, consistent with recent specialty ingredients sector valuations for scaled, multinational operations.
IFF's Chief Executive Officer Erik Fyrwald characterized the transaction as an important strategic milestone within the company's ongoing portfolio optimization initiative. The sale enables IFF to simplify its portfolio and concentrate capital and management resources on its higher-growth, higher-margin segments spanning Taste, Scent, and Health & Biosciences. Management indicated the transaction will accelerate innovation and drive increased R&D investment while facilitating more effective integration of the company's biotechnology and naturals capabilities across its global platform. By retaining a meaningful minority stake, IFF shareholders maintain exposure to the upside potential of what management describes as a strong business operating under dedicated private equity ownership.
The transaction strengthens IFF's balance sheet and capital structure while positioning the company for sustained, profitable long-term growth focused on its core innovation-driven segments. The deal represents one of the largest transactions in the specialty ingredients sector in recent periods, reflecting continued appetite from large-scale buyout firms for established, cash-generative businesses with multinational customer relationships and technical capabilities in specialty food ingredients.
The Food Ingredients business represents a substantial asset on IFF's balance sheet. In 2025, the division generated nearly $3.1 billion in annual sales and approximately $430 million of EBITDA, reflecting meaningful profitability across a diversified portfolio that includes texturants, emulsifiers, plant-based solutions, and specialty ingredients serving multinational food and beverage customers. The deal values this business at an enterprise value implying an approximate 10x EBITDA multiple, consistent with recent specialty ingredients sector valuations for scaled, multinational operations.
IFF's Chief Executive Officer Erik Fyrwald characterized the transaction as an important strategic milestone within the company's ongoing portfolio optimization initiative. The sale enables IFF to simplify its portfolio and concentrate capital and management resources on its higher-growth, higher-margin segments spanning Taste, Scent, and Health & Biosciences. Management indicated the transaction will accelerate innovation and drive increased R&D investment while facilitating more effective integration of the company's biotechnology and naturals capabilities across its global platform. By retaining a meaningful minority stake, IFF shareholders maintain exposure to the upside potential of what management describes as a strong business operating under dedicated private equity ownership.
The transaction strengthens IFF's balance sheet and capital structure while positioning the company for sustained, profitable long-term growth focused on its core innovation-driven segments. The deal represents one of the largest transactions in the specialty ingredients sector in recent periods, reflecting continued appetite from large-scale buyout firms for established, cash-generative businesses with multinational customer relationships and technical capabilities in specialty food ingredients.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.